Neurocognitive Impairment Is an Independent Risk Factor for Death in HIV Infection
- 1 April 1997
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 54 (4) , 416-424
- https://doi.org/10.1001/archneur.1997.00550160054016
Abstract
Objective: To determine if mortality is increased in individuals with human immunodeficiency virus type 1 (HIV-1)-associated neurocognitive disorders less severe than frank dementia. Design: A prospective cohort study; median duration of follow-up was 2.4 years. Kaplan-Meier analysis and Cox proportional hazards models were used to compare survival times according to neurocognitive classification. Setting: University-based research unit. Participants: A volunteer sample of 414 individuals seropositive for HIV-1. Subjects were classified at their base-line evaluation as neuropsychologically (NP) normal or abnormal (impaired in ≥2 NP test domains). A subgroup of NP abnormal subjects met operational criteria for HIV-associated minor cognitive motor disorder; the remaining subjects were designated NP impaired. Subjects with frank dementia were excluded. Main Outcome Measure: Mortality. Results: At the baseline evaluation, 256 (62%) of 414 subjects were designated normal; 109 (26%), NP impaired; and 49 (12%), minor cognitive motor disorder. One hundred six participants (26%) died during follow-up. Compared with the NP normal group, the unadjusted relative risk (RR) of death for all NP abnormal subjects (minor cognitive motor disorder and NP impaired) was significantly increased (RR, 1.7; 95% confidence interval [CI], 1.2-2.6;P<.005). After adjusting for concurrently measured predictors of survival (CD4 lymphocyte counts, Centers for Disease Control and Prevention HIV disease classification, hemoglobin concentration, and serum β2-microglobulin) in proportional hazards models, mortality for all NP abnormal subjects remained elevated (RR, 1.8; 95% CI, 1.2-2.8;P<.01). The elevation in mortality risk for subjects with minor cognitive motor disorder was statistically significant (RR, 2.2; 95% CI, 1.2-3.8;P<.01); for NP impaired subjects it was marginally significant (RR, 1.6; 95% CI, 1.0-2.8;P=.06). Conclusions: The HIV-infected individuals with NP impairment had a higher risk of dying than those without impairment. This was particularly true for those meeting syndromic diagnostic criteria.Keywords
This publication has 21 references indexed in Scilit:
- A follow-up study of neuropsychological functioning in AIDS-patients Prognostic significance and effect of zidovudine therapyActa Neurologica Scandinavica, 2009
- Indices of relative weight and obesityPublished by Elsevier ,2004
- Subjective complaints of cognitive symptoms are related to psychometric findings of memory deficits in patients with HIV-1 infectionJournal of the International Neuropsychological Society, 1996
- Do asymptomatic HIV-seropositive individuals show cognitive deficit?AIDS, 1995
- The role of initial AIDS-defining illness in survival following AIDSAIDS, 1995
- Lower socioeconomic status and shorter survival following HIV infectionThe Lancet, 1994
- Assessment of Aids-related cognitive changes: Recommendations of the NIMH workshop on neuropsychological assessment approachesJournal of Clinical and Experimental Neuropsychology, 1990
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960
- THE ASSESSMENT OF ANXIETY STATES BY RATINGPsychology and Psychotherapy: Theory, Research and Practice, 1959
- Extension of Multiple Range Tests to Group Means with Unequal Numbers of ReplicationsPublished by JSTOR ,1956